LIVE WEBINAR
Interferons: From Basic Biology to Translational Applications
Interferons (IFNs) are pivotal cytokines orchestrating antiviral defense, immune modulation, and oncological responses. However, despite decades of clinical application, their broad therapeutic utility is frequently hindered by systemic toxicity, off-target effects, and unpredictable patient heterogeneity.This webinar introduces the fundamental biology of interferons, addressing the critical question of why there are so many interferon subtypes and exploring their unique biological significance.
DATE
April 30, 2026 | 15:00 PM (CET)
LOCATION
Online | Zoom
Introduction & Summary
Interferons (IFNs) are pivotal cytokines orchestrating antiviral defense, immune modulation, and oncological responses. However, despite decades of clinical application, their broad therapeutic utility is frequently hindered by systemic toxicity, off-target effects, and unpredictable patient heterogeneity.This webinar introduces the fundamental biology of interferons, addressing the critical question of why there are so many interferon subtypes and exploring their unique biological significance. Crucially, the translation of next-generation precision treatments demands highly predictive in vivo environments. We will explore the vital role of specialized humanized animal models, specifically the hIFNAR mouse model, in accurately evaluating therapeutic efficacy and bridging the gap between basic virology and clinical success. Join us to discover how advanced models and precision research strategies can streamline your workflow and efficiently advance your targeted IFN therapeutics.
Topic Covered
- Interferon System Overview: Understanding the fundamental biology, current clinical applications, and existing limitations of interferon therapies.
- Decoding Subtype Diversity: Exploring the biological significance, functional divergence, and biased agonism among the multitude of interferon subtypes.
- Preclinical Bridges: How the humanized IFNAR (hIFNAR) mouse model overcomes species-specific limitations to empower high-fidelity basic studies and translational research.
- The Future of Precision Therapeutics: Strategies for translating mechanistic discoveries into targeted, precision IFN treatments with enhanced efficacy and minimized adverse effects.
Who should attend:
- Antiviral & Immuno-Oncology Researchers: Exploring IFN immune regulation in viral infections and malignant tumors.
- Biopharma R&D Scientists: Developing targeted Type I/III interferon and cytokine therapies while minimizing systemic toxicity.
- Translational Medicine Leaders: Seeking predictive in vivo solutions (e.g., hIFNAR models) for robust PD/PK validation.
- Autoimmune Disease Experts: Investigating IFN pathway interventions for conditions like SLE and MS.
- Pharmacology Platform Heads: De-risking the bench-to-bedside journey using advanced humanized models for drug screening.
Webinar Presenter
{{value.name}}
{{value.title}}
{{value.company}}
Discover Our Solutions
{{ value.label }}
{{ value.name }}
Explore
Request Information About This Webinar
Whether you're joining live or catching up later, fill out the form to receive materials or updates related to this webinar.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
